NAD--azoferredoxin (ADP-ribose)transferase
RxNorm 391676
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 391676 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: NAD--azoferredoxin (ADP-ribose)transferase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
NAD(+)--dinitrogen-reductase ADP-D-ribosyltransferase
(Atom ID: 1632843)
SY
Synonym (SY):
NAD--azoferredoxin (ADP-ribose)transferase
(Atom ID: 1632844)
SY
Synonym (SY):
Nicotinamide adenine dinucleotide (NAD) (+)--dinitrogen-reductase adenosine diphosphate-D-ribosyltransferase
(Atom ID: 2546555)
SY
Synonym (SY):
Nicotinamide adenine dinucleotide dinitrogen-reductase adenosine diphosphate-D-ribosyltransferase
(Atom ID: 4247972)
FN